Briviact (UCB, Inc.)
Welcome to the PulseAid listing for the Briviact drug offered from UCB, Inc.. This Epoxide Hydrolase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | UCB, Inc. |
NON-PROPRIETARY NAME: | brivaracetam |
SUBSTANCE NAME: | BRIVARACETAM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Epoxide Hydrolase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-05-12 |
END MARKETING DATE: | 0000-00-00 |
Briviact HUMAN PRESCRIPTION DRUG Details:
Item Description | Briviact from UCB, Inc. |
LABELER NAME: | UCB, Inc. |
DEA SCHEDULE: | CV
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2016-05-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50474-370_7d59b2b8-0e38-4a6a-8e63-488ca47a0288 |
PRODUCT NDC: | 50474-370 |
APPLICATION NUMBER: | NDA205836 |
Other BRIVARACETAM Pharmaceutical Manufacturers / Labelers: